Acute Respiratory Distress Syndrome Clinical Trial
Official title:
Palliative Use of High-flow Oxygen Nasal Cannula in End-of-life Patients: a Randomized Controlled Trial
The prevalence of severe dyspnoea among terminally ill patients has been reported as 70% and
90% for lung cancer and chronic obstructive pulmonary disease (COPD) patients, respectively.
Current management to dyspnoea includes opioids, psychotropic drugs, inhaled frusemide,
Heliox 28 and oxygen.
Conventional oxygen supplementation is often used in these patients, but it may be
inadequate, especially if they require high flows (from 30L/min to 120L/min in acute
respiratory failure).
High-flow oxygen nasal cannula (HFONC) is a new technological device in high-flow oxygen
system that consists of an air-oxygen blender (allowing from 21% to 100% FiO2) which
generates the gas flow rate up to 55 L/min and a heated humidification system. This
technology may have an important role in reducing respiratory distress in do-not-intubate
patients.
Some HFONC's beneficial effects are the washout of the nasopharyngeal dead space reducing
rebreathing of CO2 and improvement oxygenation through greater alveolar oxygen
concentration; a better matching between patient's inspiratory demand and oxygen flow;
generation of a certain level of positive pressure (PEEP) contributing to the pulmonary
distending pressure and recruitment; improvement of lung and airway mucociliary clearance
due to the heated and humidified oxygen; and patient's comfort because of the nasal
interface allowing feeding and speech.
The investigators hypothesize that patients supported with HFONC need less opioids to
decrease dyspnoea.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04384445 -
Zofin (Organicell Flow) for Patients With COVID-19
|
Phase 1/Phase 2 | |
Recruiting |
NCT05535543 -
Change in the Phase III Slope of the Volumetric Capnography by Prone Positioning in Acute Respiratory Distress Syndrome
|
||
Completed |
NCT04695392 -
Restore Resilience in Critically Ill Children
|
N/A | |
Terminated |
NCT04972318 -
Two Different Ventilatory Strategies in Acute Respiratory Distress Syndrome Due to Community-acquired Pneumonia
|
N/A | |
Completed |
NCT04534569 -
Expert Panel Statement for the Respiratory Management of COVID-19 Related Acute Respiratory Failure (C-ARF)
|
||
Completed |
NCT04078984 -
Driving Pressure as a Predictor of Mechanical Ventilation Weaning Time on Post-ARDS Patients in Pressure Support Ventilation.
|
||
Completed |
NCT04451291 -
Study of Decidual Stromal Cells to Treat COVID-19 Respiratory Failure
|
N/A | |
Not yet recruiting |
NCT06254313 -
The Role of Cxcr4Hi neutrOPhils in InflueNza
|
||
Not yet recruiting |
NCT04798716 -
The Use of Exosomes for the Treatment of Acute Respiratory Distress Syndrome or Novel Coronavirus Pneumonia Caused by COVID-19
|
Phase 1/Phase 2 | |
Withdrawn |
NCT04909879 -
Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Non-COVID-19 Acute Respiratory Distress Syndrome
|
Phase 2 | |
Not yet recruiting |
NCT02881385 -
Effects on Respiratory Patterns and Patient-ventilator Synchrony Using Pressure Support Ventilation
|
N/A | |
Terminated |
NCT02867228 -
Noninvasive Estimation of Work of Breathing
|
N/A | |
Completed |
NCT02545621 -
A Role for RAGE/TXNIP/Inflammasome Axis in Alveolar Macrophage Activation During ARDS (RIAMA): a Proof-of-concept Clinical Study
|
||
Completed |
NCT02232841 -
Electrical Impedance Imaging of Patients on Mechanical Ventilation
|
N/A | |
Withdrawn |
NCT01927237 -
Pulmonary Vascular Effects of Respiratory Rate & Carbon Dioxide
|
N/A | |
Completed |
NCT02889770 -
Dead Space Monitoring With Volumetric Capnography in ARDS Patients
|
N/A | |
Completed |
NCT01504893 -
Very Low Tidal Volume vs Conventional Ventilatory Strategy for One-lung Ventilation in Thoracic Anesthesia
|
N/A | |
Completed |
NCT02814994 -
Respiratory System Compliance Guided VT in Moderate to Severe ARDS Patients
|
N/A | |
Completed |
NCT01680783 -
Non-Invasive Ventilation Via a Helmet Device for Patients Respiratory Failure
|
N/A | |
Completed |
NCT02214576 -
High Flow Nasal Canula Oxygen Helps Preoxygenate ARDS Patients
|
N/A |